Tom 11, Nr 1 (2019)
Artykuły
Opublikowany online: 2019-05-02

dostęp otwarty

Wyświetlenia strony 584
Wyświetlenia/pobrania artykułu 163
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

24-godzinne wielokanałowe monitorowanie impedancji i pH w przełyku — evidence based medicine

Agnieszka Świdnicka-Siergiejko
Gastroenterologia Kliniczna 2019;11(1):3-8.

Streszczenie

24-godzinne monitorowanie impedancji i pH w przełyku poszerzyło wiedzę o chorobie refluksowej, szczególnie o właściwościach fizycznych i chemicznych treści, która jest zarzucana do przełyku. Wiedza ta jest bezcenna w diagnostyce i skutecznym leczeniu opornej na leczenie inhibitorami pompy protonowej chorobie refluksowej, w postępowaniu u chorych objawami pozaprzełykowymi oraz u osób kwalifikowanych do zabiegów antyrefluksowych. Badanie to stało się podstawowym narzędziem diagnostycznym w specjalistycznym postępowaniu gastroenterologicznym.

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004; 53(7): 1024–1031.
  2. Bredenoord AJ, Weusten BL, Timmer R, et al. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol. 2006; 101(3): 453–459.
  3. Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis. 2011; 43(7): 542–547.
  4. Ravi K, Katzka DA. Esophageal Impedance Monitoring: Clinical Pearls and Pitfalls. Am J Gastroenterol. 2016; 111(9): 1245–1256.
  5. Roman S, Gyawali CP, Savarino E, et al. GERD consensus group. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017; 29(10): 1–15.
  6. Patel DA, Vaezi MF. Utility of esophageal mucosal impedance as a diagnostic test for esophageal disease. Curr Opin Gastroenterol. 2017; 33(4): 277–284.
  7. Frazzoni M, de Bortoli N, Frazzoni L, et al. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Dig Dis Sci. 2017; 62(8): 1881–1889.
  8. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018; 67(7): 1351–1362.
  9. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013; 108(3): 308–28; quiz 329.
  10. Vaezi MF, Sifrim D. Assessing Old and New Diagnostic Tests for Gastroesophageal Reflux Disease. Gastroenterology. 2018; 154(2): 289–301.
  11. Kessing BF, Bredenoord AJ, Smout AJ. The pathophysiology, diagnosis and treatment of excessive belching symptoms. Am J Gastroenterol. 2014; 109(8): 1196–203); (Quiz) 1204.
  12. Kessing BF, Smout AJ, Bredenoord AJ. Current diagnosis and management of the rumination syndrome. J Clin Gastroenterol. 2014; 48(6): 478–483.
  13. Wang A, Pleskow DK, Banerjee S, et al. ASGE Technology Committee. Esophageal function testing. Gastrointest Endosc. 2012; 76(2): 231–243.
  14. Kline MM, Ewing M, Simpson N, et al. The utility of intraluminal impedance in patients with gastroesophageal reflux disease-like symptoms but normal endoscopy and 24-hour pH testing. Clin Gastroenterol Hepatol. 2008; 6(8): 880–885.
  15. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006; 101(9): 1956–1963.
  16. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006; 55(10): 1398–1402.
  17. Kahrilas PJ, Keefer L, Pandolfino JE. Patients with refractory reflux symptoms: What do they have and how should they be managed? Neurogastroenterol Motil. 2015; 27(9): 1195–1201.
  18. Savarino E, Zentilin P, Tutuian R, et al. Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol. 2012; 47(2): 159–168.
  19. Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol. 2008; 103(11): 2685–2693.
  20. Savarino E, Pohl D, Zentilin P, et al. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009; 58(9): 1185–1191.
  21. Jodorkovsky D, Price JC, Kim B, et al. Multichannel intraluminal impedance-pH testing is clinically useful in the management of patients with gastroesophageal reflux symptoms. Dig Dis Sci. 2014; 59(8): 1817–1822.
  22. Patel A, Sayuk GS, Kushnir VM, et al. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation. Neurogastroenterol Motil. 2016; 28(4): 513–521.
  23. Patel A, Sayuk GS, Gyawali CP. Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters. Am J Gastroenterol. 2014; 109(6): 836–844.
  24. Rosen R, Levine P, Lewis J, et al. Reflux events detected by pH-MII do not determine fundoplication outcome. J Pediatr Gastroenterol Nutr. 2010; 50(3): 251–255.
  25. Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg. 2006; 93(12): 1483–1487.
  26. Frazzoni M, Piccoli M, Conigliaro R, et al. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication. Surg Endosc. 2013; 27(8): 2940–2946.
  27. Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2015; 13(5): 884–891.
  28. Sifrim D, Dupont L, Blondeau K, et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut. 2005; 54(4): 449–454.
  29. Blondeau K, Dupont LJ, Mertens V, et al. Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough. Aliment Pharmacol Ther. 2007; 25(6): 723–732.
  30. Bajbouj M, Becker V, Neuber M, et al. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion. 2007; 76(3-4): 223–228.
  31. Francis DO, Goutte M, Slaughter JC, et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope. 2011; 121(9): 1902–1909.
  32. Swoger J, Ponsky J, Hicks DM, et al. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol. 2006; 4(4): 433–441.